INJEX Pharma GmbH, based in Berlin, pioneered needle free injections for intradermal and subcutaneous applications since almost two decades. The INJEX needle free technology is used for medical and cosmetic treatments. Today the INJEX Pharma Group has offices in Germany and China. “I am very excited to have Abel Health Technologies and Hefei Xuruikang Technology as strong strategic partners with excellent access to the fast growing Chinese market. And as a Chinese-German company we will be able to combine the respective comparative advantages of both countries”, says INJEX Pharma Group CEO Dr. Thomas Klaue. Abel Health Technologies has established a wide distribution network for medical products and is a partner of China Sinopharm, one of the largest pharmaceutical distributors in China, and Hefei Xuruikang Technology is focussing on the online sales channel.